The latest price target for Vigil Neuroscience (NASDAQ:VIGL) was reported by Wedbush on November 8, 2024. The analyst firm set a price target for $24.00 expecting VIGL to rise to within 12 months (a possible 713.56% upside). 15 analyst firms have reported ratings in the last year.

The latest analyst rating for Vigil Neuroscience (NASDAQ:VIGL) was provided by Wedbush, and Vigil Neuroscience maintained their outperform rating.

There is no last upgrade for Vigil Neuroscience

The last downgrade for Vigil Neuroscience Inc happened on December 19, 2023 when Morgan Stanley changed their price target from $13 to $4 for Vigil Neuroscience Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vigil Neuroscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vigil Neuroscience was filed on November 8, 2024 so you should expect the next rating to be made available sometime around November 8, 2025.

While ratings are subjective and will change, the latest Vigil Neuroscience (VIGL) rating was a maintained with a price target of $23.00 to $24.00. The current price Vigil Neuroscience (VIGL) is trading at is $2.95, which is out of the analyst’s predicted range.